Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
Clinical trial NCT06807606 · RECRUITING
Trial details
- NCT number
- NCT06807606
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2027-11-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.